Cerebral Cavernous Malformation
8 clinical trials · Condition
◉ Watch Cerebral Cavernous Malformation
| Record | Firm | Date |
|---|---|---|
| The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 (NCT05085561) | Recursion Pharmaceuticals Inc. | 2022-03-17 |
| CCM Blood Biomarker Validation Study (NCT05148663) | Texas Tech University Health Sciences Center, El Paso | 2021-01-01 |
| Biomarkers of CASH (NCT04467489) | University of Chicago | 2020-05-22 |
| Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial (NCT02603328) | University of Chicago | 2018-07-17 |
| Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation (NCT03589014) | Mario Negri Institute for Pharmacological Research | 2018-04-11 |
| CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study (NCT02946866) | Seoul National University Hospital | 2016-06-01 |
Track Cerebral Cavernous Malformation automatically
Every clearance here is in the API, with alerts when new ones post.